The market does indeed continue to grow. It would be interesting to know how the estimate segments between research and clinical.
Biomarkers Market Exceeds 25 Billion: Kalorama Report
Oct 30, 2013 | News
As COVID-19 infections continue to spread, organizations with technologies or devices that can support new drug, vaccine, or test development have a life-saving contribution to make. The Amplion Intelligence Platform can alert you to new COVID-19 trial activities in real-time and automatically match you to partners who need your unique capabilities immediately. It’s already tomorrow somewhere, so let us help you start today. Learn More